Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 2, 2011, before the open
10-Q filed Aug 2, 2011, 33 days after period end · 0001104659-11-042450
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Net Income | -$21.47M | $27.03M |
| EPS Diluted | -$0.37 | $0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 2, 2011 · 33 d after period end
14.2% from the close of Jul 29, 2011 to the close of Aug 4, 2011, the first after the release.
